Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.
Identifieur interne : 000B54 ( Main/Exploration ); précédent : 000B53; suivant : 000B55Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.
Auteurs : S L Kilbreath [Australie] ; K M Refshauge [Australie] ; J M Beith [Australie] ; L C Ward [Australie] ; O A Ung [Australie] ; E S Dylke [Australie] ; J R French [Australie] ; J. Yee [Australie] ; L. Koelmeyer [Australie] ; K. Gaitatzis [Australie]Source :
- Breast (Edinburgh, Scotland) [ 1532-3080 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Bras, Complications postopératoires (étiologie), Composés pontés (administration et posologie), Facteurs de risque, Facteurs temps, Femelle, Humains, Lymphadénectomie (effets indésirables), Lymphoedème (diagnostic), Lymphoedème (étiologie), Mastectomie (effets indésirables), Métastase lymphatique, Phlébotomie (effets indésirables), Poids du corps, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Radiothérapie (effets indésirables), Sujet âgé, Taxoïdes (administration et posologie), Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Études de suivi, Études prospectives.
- MESH :
- administration et posologie : Composés pontés, Taxoïdes.
- anatomopathologie : Tumeurs du sein.
- diagnostic : Lymphoedème.
- effets indésirables : Lymphadénectomie, Mastectomie, Phlébotomie, Protocoles de polychimiothérapie antinéoplasique, Radiothérapie.
- étiologie : Complications postopératoires, Lymphoedème.
- Adulte, Adulte d'âge moyen, Aisselle, Bras, Facteurs de risque, Facteurs temps, Femelle, Humains, Métastase lymphatique, Poids du corps, Sujet âgé, Tumeurs du sein, Études de suivi, Études prospectives.
English descriptors
- KwdEn :
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Arm, Axilla, Body Weight, Breast Neoplasms (pathology), Breast Neoplasms (therapy), Bridged-Ring Compounds (administration & dosage), Female, Follow-Up Studies, Humans, Lymph Node Excision (adverse effects), Lymphatic Metastasis, Lymphedema (diagnosis), Lymphedema (etiology), Mastectomy (adverse effects), Middle Aged, Phlebotomy (adverse effects), Postoperative Complications (etiology), Prospective Studies, Radiotherapy (adverse effects), Risk Factors, Taxoids (administration & dosage), Time Factors.
- MESH :
- chemical , administration & dosage : Bridged-Ring Compounds, Taxoids.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Lymph Node Excision, Mastectomy, Phlebotomy, Radiotherapy.
- diagnosis : Lymphedema.
- etiology : Lymphedema, Postoperative Complications.
- pathology : Breast Neoplasms.
- therapy : Breast Neoplasms.
- Adult, Aged, Arm, Axilla, Body Weight, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Prospective Studies, Risk Factors, Time Factors.
Abstract
A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on axillary surgery. Assessment occurred prior to surgery, within 4 weeks, and at 6, 12 and 18 months following surgery. Following post-surgery assessment, women were asked to complete weekly diaries regarding events that occurred in the previous week. Risk factors were grouped into demographic, lifestyle, breast cancer treatment-related, arm swelling-related, and post-surgical activities. Bioimpedance spectroscopy thresholds were used to determine presence of LE. At 18-months, 241 women with <5 nodes removed and 209 women with ≥5 nodes removed were assessed. For those with <5 nodes removed, LE was present in 3.3% compared with 18.2% for those with ≥5 nodes removed. There were insufficient events to identify risk factors for those with <5 nodes removed; for those with >5 nodes removed, independent risk factors included presence of arm swelling at 12-months (Odds Ratio (OR): 13.5, 95% CI 4.8, 38.1; P < 0.01), at 6-months (5.6 (2.0, 16.9); P < 0.01), and radiotherapy to the axilla (2.6 (0.7, 8.9); P = 0.14). Arm swelling at 6 and 12 months was associated with taxane-based chemotherapy, high body weight at diagnosis and arm swelling within 4 weeks post-surgery. Of the post-surgical events assessed in a sub-group of women with >5 nodes removed and who maintained weekly diaries, only blood drawn from the 'at-risk' arm was identified as a potential risk (OR 2.0; 0.8, 5.2). For women with ≥5 nodes removed, arm swelling in the first year poses a very strong risk for presence of LE at 18-months.
DOI: 10.1016/j.breast.2016.04.011
PubMed: 27183497
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000821
- to stream PubMed, to step Curation: 000821
- to stream PubMed, to step Checkpoint: 000821
- to stream Ncbi, to step Merge: 008296
- to stream Ncbi, to step Curation: 008296
- to stream Ncbi, to step Checkpoint: 008296
- to stream Main, to step Merge: 000B55
- to stream Main, to step Curation: 000B54
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.</title><author><name sortKey="Kilbreath, S L" sort="Kilbreath, S L" uniqKey="Kilbreath S" first="S L" last="Kilbreath">S L Kilbreath</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia. Electronic address: sharon.kilbreath@sydney.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Refshauge, K M" sort="Refshauge, K M" uniqKey="Refshauge K" first="K M" last="Refshauge">K M Refshauge</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Beith, J M" sort="Beith, J M" uniqKey="Beith J" first="J M" last="Beith">J M Beith</name><affiliation wicri:level="1"><nlm:affiliation>Chris O'Brien Lifehouse, Camperdown, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Chris O'Brien Lifehouse, Camperdown</wicri:regionArea><wicri:noRegion>Camperdown</wicri:noRegion></affiliation></author><author><name sortKey="Ward, L C" sort="Ward, L C" uniqKey="Ward L" first="L C" last="Ward">L C Ward</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Ung, O A" sort="Ung, O A" uniqKey="Ung O" first="O A" last="Ung">O A Ung</name><affiliation wicri:level="1"><nlm:affiliation>Royal Brisbane and Women's Hospital, School of Medicine, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Royal Brisbane and Women's Hospital, School of Medicine, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Dylke, E S" sort="Dylke, E S" uniqKey="Dylke E" first="E S" last="Dylke">E S Dylke</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="French, J R" sort="French, J R" uniqKey="French J" first="J R" last="French">J R French</name><affiliation wicri:level="1"><nlm:affiliation>Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Westmead Breast Cancer Institute, Westmead Hospital, Westmead</wicri:regionArea><wicri:noRegion>Westmead</wicri:noRegion></affiliation></author><author><name sortKey="Yee, J" sort="Yee, J" uniqKey="Yee J" first="J" last="Yee">J. Yee</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Koelmeyer, L" sort="Koelmeyer, L" uniqKey="Koelmeyer L" first="L" last="Koelmeyer">L. Koelmeyer</name><affiliation wicri:level="1"><nlm:affiliation>Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Westmead Breast Cancer Institute, Westmead Hospital, Westmead</wicri:regionArea><wicri:noRegion>Westmead</wicri:noRegion></affiliation></author><author><name sortKey="Gaitatzis, K" sort="Gaitatzis, K" uniqKey="Gaitatzis K" first="K" last="Gaitatzis">K. Gaitatzis</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27183497</idno><idno type="pmid">27183497</idno><idno type="doi">10.1016/j.breast.2016.04.011</idno><idno type="wicri:Area/PubMed/Corpus">000821</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000821</idno><idno type="wicri:Area/PubMed/Curation">000821</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000821</idno><idno type="wicri:Area/PubMed/Checkpoint">000821</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000821</idno><idno type="wicri:Area/Ncbi/Merge">008296</idno><idno type="wicri:Area/Ncbi/Curation">008296</idno><idno type="wicri:Area/Ncbi/Checkpoint">008296</idno><idno type="wicri:Area/Main/Merge">000B55</idno><idno type="wicri:Area/Main/Curation">000B54</idno><idno type="wicri:Area/Main/Exploration">000B54</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.</title><author><name sortKey="Kilbreath, S L" sort="Kilbreath, S L" uniqKey="Kilbreath S" first="S L" last="Kilbreath">S L Kilbreath</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia. Electronic address: sharon.kilbreath@sydney.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Refshauge, K M" sort="Refshauge, K M" uniqKey="Refshauge K" first="K M" last="Refshauge">K M Refshauge</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Beith, J M" sort="Beith, J M" uniqKey="Beith J" first="J M" last="Beith">J M Beith</name><affiliation wicri:level="1"><nlm:affiliation>Chris O'Brien Lifehouse, Camperdown, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Chris O'Brien Lifehouse, Camperdown</wicri:regionArea><wicri:noRegion>Camperdown</wicri:noRegion></affiliation></author><author><name sortKey="Ward, L C" sort="Ward, L C" uniqKey="Ward L" first="L C" last="Ward">L C Ward</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Ung, O A" sort="Ung, O A" uniqKey="Ung O" first="O A" last="Ung">O A Ung</name><affiliation wicri:level="1"><nlm:affiliation>Royal Brisbane and Women's Hospital, School of Medicine, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Royal Brisbane and Women's Hospital, School of Medicine, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Dylke, E S" sort="Dylke, E S" uniqKey="Dylke E" first="E S" last="Dylke">E S Dylke</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="French, J R" sort="French, J R" uniqKey="French J" first="J R" last="French">J R French</name><affiliation wicri:level="1"><nlm:affiliation>Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Westmead Breast Cancer Institute, Westmead Hospital, Westmead</wicri:regionArea><wicri:noRegion>Westmead</wicri:noRegion></affiliation></author><author><name sortKey="Yee, J" sort="Yee, J" uniqKey="Yee J" first="J" last="Yee">J. Yee</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Koelmeyer, L" sort="Koelmeyer, L" uniqKey="Koelmeyer L" first="L" last="Koelmeyer">L. Koelmeyer</name><affiliation wicri:level="1"><nlm:affiliation>Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Westmead Breast Cancer Institute, Westmead Hospital, Westmead</wicri:regionArea><wicri:noRegion>Westmead</wicri:noRegion></affiliation></author><author><name sortKey="Gaitatzis, K" sort="Gaitatzis, K" uniqKey="Gaitatzis K" first="K" last="Gaitatzis">K. Gaitatzis</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Health Sciences, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></analytic><series><title level="j">Breast (Edinburgh, Scotland)</title><idno type="eISSN">1532-3080</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Arm</term><term>Axilla</term><term>Body Weight</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (therapy)</term><term>Bridged-Ring Compounds (administration & dosage)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphatic Metastasis</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Mastectomy (adverse effects)</term><term>Middle Aged</term><term>Phlebotomy (adverse effects)</term><term>Postoperative Complications (etiology)</term><term>Prospective Studies</term><term>Radiotherapy (adverse effects)</term><term>Risk Factors</term><term>Taxoids (administration & dosage)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Bras</term><term>Complications postopératoires (étiologie)</term><term>Composés pontés (administration et posologie)</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Mastectomie (effets indésirables)</term><term>Métastase lymphatique</term><term>Phlébotomie (effets indésirables)</term><term>Poids du corps</term><term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term><term>Radiothérapie (effets indésirables)</term><term>Sujet âgé</term><term>Taxoïdes (administration et posologie)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Bridged-Ring Compounds</term><term>Taxoids</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Composés pontés</term><term>Taxoïdes</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Lymph Node Excision</term><term>Mastectomy</term><term>Phlebotomy</term><term>Radiotherapy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term><term>Mastectomie</term><term>Phlébotomie</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Radiothérapie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Arm</term><term>Axilla</term><term>Body Weight</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Prospective Studies</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Bras</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Métastase lymphatique</term><term>Poids du corps</term><term>Sujet âgé</term><term>Tumeurs du sein</term><term>Études de suivi</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on axillary surgery. Assessment occurred prior to surgery, within 4 weeks, and at 6, 12 and 18 months following surgery. Following post-surgery assessment, women were asked to complete weekly diaries regarding events that occurred in the previous week. Risk factors were grouped into demographic, lifestyle, breast cancer treatment-related, arm swelling-related, and post-surgical activities. Bioimpedance spectroscopy thresholds were used to determine presence of LE. At 18-months, 241 women with <5 nodes removed and 209 women with ≥5 nodes removed were assessed. For those with <5 nodes removed, LE was present in 3.3% compared with 18.2% for those with ≥5 nodes removed. There were insufficient events to identify risk factors for those with <5 nodes removed; for those with >5 nodes removed, independent risk factors included presence of arm swelling at 12-months (Odds Ratio (OR): 13.5, 95% CI 4.8, 38.1; P < 0.01), at 6-months (5.6 (2.0, 16.9); P < 0.01), and radiotherapy to the axilla (2.6 (0.7, 8.9); P = 0.14). Arm swelling at 6 and 12 months was associated with taxane-based chemotherapy, high body weight at diagnosis and arm swelling within 4 weeks post-surgery. Of the post-surgical events assessed in a sub-group of women with >5 nodes removed and who maintained weekly diaries, only blood drawn from the 'at-risk' arm was identified as a potential risk (OR 2.0; 0.8, 5.2). For women with ≥5 nodes removed, arm swelling in the first year poses a very strong risk for presence of LE at 18-months.</div></front></TEI><affiliations><list><country><li>Australie</li></country><region><li>Nouvelle-Galles du Sud</li></region><settlement><li>Sydney</li></settlement></list><tree><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Kilbreath, S L" sort="Kilbreath, S L" uniqKey="Kilbreath S" first="S L" last="Kilbreath">S L Kilbreath</name></region><name sortKey="Beith, J M" sort="Beith, J M" uniqKey="Beith J" first="J M" last="Beith">J M Beith</name><name sortKey="Dylke, E S" sort="Dylke, E S" uniqKey="Dylke E" first="E S" last="Dylke">E S Dylke</name><name sortKey="French, J R" sort="French, J R" uniqKey="French J" first="J R" last="French">J R French</name><name sortKey="Gaitatzis, K" sort="Gaitatzis, K" uniqKey="Gaitatzis K" first="K" last="Gaitatzis">K. Gaitatzis</name><name sortKey="Koelmeyer, L" sort="Koelmeyer, L" uniqKey="Koelmeyer L" first="L" last="Koelmeyer">L. Koelmeyer</name><name sortKey="Refshauge, K M" sort="Refshauge, K M" uniqKey="Refshauge K" first="K M" last="Refshauge">K M Refshauge</name><name sortKey="Ung, O A" sort="Ung, O A" uniqKey="Ung O" first="O A" last="Ung">O A Ung</name><name sortKey="Ward, L C" sort="Ward, L C" uniqKey="Ward L" first="L C" last="Ward">L C Ward</name><name sortKey="Yee, J" sort="Yee, J" uniqKey="Yee J" first="J" last="Yee">J. Yee</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27183497
|texte= Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27183497" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |